CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

SHE:300765 Revenue

CSPC Innovation Pharmaceutical had revenue of 664.65M CNY in the quarter ending March 31, 2026, with 40.82% growth. This brings the company's revenue in the last twelve months to 2.35B, up 21.87% year-over-year. In the year 2025, CSPC Innovation Pharmaceutical had annual revenue of 2.16B with 8.93% growth.

• Revenue (ttm): 2.35B
• Revenue Growth: +21.87%
• P/S Ratio: 17.99
• Revenue / Employee: 992.13K
• Employees: 2,369
• Market Cap: 42.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.16B	176.93M	8.93%
Dec 31, 2024	1.98B	-557.96M	-21.98%
Dec 31, 2023	2.54B	-87.78M	-3.34%
Jan 1, 2023	2.63B	776.81M	42.00%
Jan 1, 2022	1.85B	532.26M	40.40%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error